Tamonan, Annie M.

HRN: 21-29-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
CEFTRIAXONE 1G (VIAL)
05/11/2022
05/17/2022
IV
1G
Q12
Prophylaxis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bone & Joint    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: No    Further Investigation

Overall appropriateness: No  Indication Inappropriate

Intervention



Type of Intervention done:

                    

           


Acceptance: